ME/CFS AUSTRALIA (SA) INC
Registered Charity 698
PO Box 28,
South Australia 5007
North Terrace House,
19 North Terrace,
Hackney, SA, 5069
1300 128 339
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
Personality does not distinguish people with Fibromyalgia but identifies subgroups of patients
Friday 20 September 2013
Personality does not distinguish people with fibromyalgia but identifies subgroups of patients.
OBJECTIVES: The objectives were to compare the personality of fibromyalgia (FM) patients with other chronic painful and nonpainful disorders considering the confusion due to psychopathology and to assess the clustering of FM patients according to their personality profile.
METHODS: Differences in the NEO Five-Factor Inventory between FM, non-FM chronic pain and drug-resistant epileptic patients were assessed including the confounding effect of demographics and psychopathological status by multivariate regression analysis. Clustering of FM patients was assessed by two-step cluster analysis. Differences in clinical severity and psychosocial problems between subgroups and their outcome 6 months after multidisciplinary treatment were assessed.
RESULTS: The final sample comprised 874 patients.
CONCLUSIONS: Identifying personality-based subgroups of FM might allow implementing specific preventive strategies. FM treatment might be optimized by increasing medication compliance, improving therapeutic alliance and testing different therapeutic options and treatment sequencing for each personality subgroup.
Source: General Hospital Psychiatry, September 12, 2013. By Xavier Torres, Ph.D., Eva Bailles, Ph.D., Manuel Valdes, M.D., Ph.D., Fernando Gutierrez, Ph.D., Josep-Maria Peri, Ph.D., Anna Arias, B.Sc. (O.T., P.T.), M.Sc. (E.), Emili Gomez, M.D., Antonio Collado, M.D., Ph.D. Institut Clínic de Neurociències, Hospital Clínic de Barcelona.
The above originally appeared here.
blog comments powered by Disqus